Consolidated Cash Flow Statements (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 103,313	$ 194,490	$ 114,345
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	94,451	59,355	50,174
Share-based compensation	14,854	12,374	11,241
Deferred income tax expense (benefit)	5,457	(42,750)	2,294
Provision for inventory obsolescence	4,623	5,085	1,160
Pension funding less than pension expense	2,833	593	3,812
Loss on debt extinguishment	1,612	52,450
Asset impairment and loss on sale of assets		33,676	2,549
Gain on sale of businesses and tangible assets		(134,480)
Income from equity method investment	(8,922)	(9,704)	(13,169)
Tax benefit related to share-based compensation	(10,734)	(4,119)	(1,790)
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes and acquired businesses:
Receivables	(18,132)	5,628	4,680
Inventories	2,249	31,706	(22,873)
Accounts payable	12,994	(55,166)	9,281
Accrued liabilities	31,690	(681)	12,317
Accrued taxes	(89,427)	(10,760)	(55)
Other assets	4,542	968	12,219
Other liabilities	13,198	723	(1,622)
Net cash provided by operating activities	164,601	139,388	184,563
Cash flows from investing activities:
Capital expenditures	(40,209)	(41,010)	(40,053)
Cash used to acquire businesses, net of cash acquired	(9,979)	(860,353)	(60,519)
Proceeds from disposal of business	3,735	299,848
Proceeds from disposal of tangible assets	3,169	9,575	1,213
Net cash used for investing activities	(43,284)	(591,940)	(99,359)
Cash flows from financing activities:
Borrowings under credit arrangements	637,595	1,149,966
Payments under borrowing arrangements	(434,743)	(593,864)
Tax benefit related to share-based compensation	10,734	4,119	1,790
Proceeds from settlement of derivatives		4,024
Proceeds from exercise of stock options, net of withholding tax payments	(3,019)	2,372	4,599
Cash dividends paid	(6,678)	(11,441)	(9,410)
Debt issuance costs paid	(17,376)	(15,414)	(3,296)
Payments under share repurchase program	(93,750)	(75,000)	(50,000)
Net cash provided by (used for) financing activities	92,763	464,762	(56,317)
Effect of foreign currency exchange rate changes on cash and cash equivalents	4,129	333	(4,988)
Increase in cash and cash equivalents	218,209	12,543	23,899
Cash and cash equivalents, beginning of period	395,095	382,552	358,653
Cash and cash equivalents, end of period	$ 613,304	$ 395,095	$ 382,552